Please note, this OEL/ADE monograph also applies to dobutamine hydrochloride (CAS RN 49745-95-1), dobutamine hydrobromide (CAS RN 74753-15-4), dobutamine tartrate (CAS RN 101626-66-8), dobutamine lactobionate (CAS RN 104564-71-8), and dobutamine phosphate (CAS RN 120885-52-1). Dobutamine hydrochloride is given to patients with depressed heart function to increase the output of the heart. Dobutamine hydrochloride stimulates beta receptors in the heart. It increases the strength of the heartbeat. Its effects on heart rate and vasoconstriction are less that other similar therapeutics.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Dobutamine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.